Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ruosu An

Vascular Surgery Rowlett, TX Medical Doctor

NPI 1447541545 CMS profile 337529

7700 Lakeview Pkwy, Ste C, Rowlett, TX 75088

Open in the dashboard

General payments

$17,580

170 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ruosu An of Rowlett, TX is reported in the CMS Open Payments database as having received $17,580 across 170 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,830 5
2024 General $3,751 5
2023 General $3,802 6
2022 General $816 28
2021 General $1,400 48
2020 General $995 34
2019 General $1,986 44

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ruosu An
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Ruosu An were reported at $4,830. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Ruosu An Vascular Surgery median Middle half National median
2019 $1,986 $796 $226–$2,363 $163
2020 $995 $348 $118–$1,110 $114
2021 $1,400 $471 $158–$1,421 $132
2022 $816 $725 $222–$2,183 $149
2023 $3,802 $836 $257–$2,440 $160
2024 $3,751 $909 $252–$2,619 $164
2025 $4,830 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $12,033 11 payments
  2. Silk Road Medical, Inc. $1,134 13 payments
  3. Cardiovascular Systems Inc. $924 42 payments
  4. Endologix, Inc. $663 6 payments
  5. Biotronik Inc. $647 20 payments
  6. Bard Peripheral Vascular, Inc. $542 10 payments
  7. W. L. Gore & Associates, Inc. $498 16 payments
  8. Janssen Pharmaceuticals, Inc $198 10 payments
  9. Smith+Nephew, Inc. $149 9 payments
  10. Becton, Dickinson and Company $136 1 payment
  11. Other $657 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Long term medical supply or device loan $12,000 9 payments
  2. Food and Beverage $4,849 155 payments
  3. Travel and Lodging $666 4 payments
  4. Education $66 2 payments
Products named General payments · program years 2019–2025
  1. VenaCure 1470 Pro Et $7,220 7 payments
  2. VenaCure 1470 Pro Id $4,800 3 payments
  3. ENROUTE 0.014 Guidewire $1,077 11 payments
  4. ENROUTE Transcarotid Stent System $1,077 11 payments
  5. ENROUTE Transcarotid Neuroprotection System $1,077 11 payments
  6. ENHANCE Transcarotid Peripheral Access Kit $1,077 11 payments
  7. Diamondback Peripheral $618 25 payments
  8. PK Papyrus $455 15 payments
  9. Orsiro $441 14 payments
  10. Pulsar $441 14 payments
  11. Other $4,380 148 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$12,105

Medicare's payments for the services billed

Medicare patients

21

Average age 72

Services billed

43

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 57%
Arthritis 57%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

170 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record